Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 4 studies | 24% ± 9% | |
endothelial cell | 4 studies | 20% ± 6% | |
epithelial cell | 4 studies | 22% ± 3% | |
astrocyte | 4 studies | 20% ± 3% | |
microglial cell | 3 studies | 19% ± 3% | |
GABAergic neuron | 3 studies | 34% ± 7% | |
glutamatergic neuron | 3 studies | 42% ± 10% | |
dendritic cell | 3 studies | 17% ± 2% | |
abnormal cell | 3 studies | 21% ± 4% | |
macrophage | 3 studies | 15% ± 0% | |
oligodendrocyte | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 30% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3303.08 | 1445 / 1445 | 100% | 16.94 | 183 / 183 |
lung | 100% | 3191.55 | 578 / 578 | 100% | 22.93 | 1155 / 1155 |
prostate | 100% | 4028.29 | 245 / 245 | 100% | 21.48 | 502 / 502 |
breast | 100% | 3552.36 | 459 / 459 | 100% | 23.31 | 1117 / 1118 |
skin | 100% | 3609.72 | 1809 / 1809 | 100% | 28.46 | 471 / 472 |
stomach | 100% | 2608.77 | 359 / 359 | 100% | 15.81 | 285 / 286 |
bladder | 100% | 3751.14 | 21 / 21 | 100% | 20.52 | 502 / 504 |
uterus | 100% | 4454.72 | 170 / 170 | 100% | 23.59 | 457 / 459 |
ovary | 100% | 3945.12 | 180 / 180 | 100% | 17.43 | 428 / 430 |
thymus | 100% | 3766.17 | 653 / 653 | 100% | 20.28 | 602 / 605 |
brain | 99% | 3253.44 | 2628 / 2642 | 100% | 27.80 | 705 / 705 |
pancreas | 100% | 1829.78 | 328 / 328 | 99% | 18.94 | 177 / 178 |
intestine | 100% | 3539.98 | 966 / 966 | 99% | 17.12 | 524 / 527 |
kidney | 100% | 2809.46 | 89 / 89 | 99% | 16.59 | 889 / 901 |
adrenal gland | 100% | 3397.22 | 258 / 258 | 97% | 18.08 | 222 / 230 |
liver | 100% | 1594.96 | 226 / 226 | 96% | 11.06 | 391 / 406 |
adipose | 100% | 3275.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.12 | 29 / 29 |
spleen | 100% | 4536.45 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.91 | 1 / 1 |
blood vessel | 100% | 3125.27 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2678.07 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1963.74 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 16.98 | 77 / 80 |
peripheral blood | 90% | 1830.16 | 836 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0000717 | Biological process | nucleotide-excision repair, DNA duplex unwinding |
GO_0006281 | Biological process | DNA repair |
GO_0048568 | Biological process | embryonic organ development |
GO_0009650 | Biological process | UV protection |
GO_0006289 | Biological process | nucleotide-excision repair |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0035315 | Biological process | hair cell differentiation |
GO_0009411 | Biological process | response to UV |
GO_0001666 | Biological process | response to hypoxia |
GO_0006265 | Biological process | DNA topological change |
GO_0006915 | Biological process | apoptotic process |
GO_0008104 | Biological process | protein localization |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_1901990 | Biological process | regulation of mitotic cell cycle phase transition |
GO_0006979 | Biological process | response to oxidative stress |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0006283 | Biological process | transcription-coupled nucleotide-excision repair |
GO_0000112 | Cellular component | nucleotide-excision repair factor 3 complex |
GO_0005669 | Cellular component | transcription factor TFIID complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000439 | Cellular component | transcription factor TFIIH core complex |
GO_0097550 | Cellular component | transcription preinitiation complex |
GO_0005675 | Cellular component | transcription factor TFIIH holo complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016853 | Molecular function | isomerase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003684 | Molecular function | damaged DNA binding |
GO_0043138 | Molecular function | 3'-5' DNA helicase activity |
Gene name | ERCC3 |
Protein name | General transcription and DNA repair factor IIH helicase subunit XPB (EC 3.6.4.12) (DNA excision repair protein ERCC-3) ERCC excision repair 3, TFIIH core complex helicase subunit General transcription and DNA repair factor IIH helicase subunit XPB (TFIIH subunit XPB) (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit) (TFIIH 89 kDa subunit) (TFIIH p89) (Xeroderma pigmentosum group B-complementing protein) DNA helicase (EC 3.6.4.12) |
Synonyms | XPB XPBC |
Description | FUNCTION: ATP-dependent 3'-5' DNA helicase, component of the general transcription and DNA repair factor IIH (TFIIH) core complex, which is involved in general and transcription-coupled nucleotide excision repair (NER) of damaged DNA and, when complexed to CAK, in RNA transcription by RNA polymerase II. In NER, TFIIH acts by opening DNA around the lesion to allow the excision of the damaged oligonucleotide and its replacement by a new DNA fragment. The ATPase activity of XPB/ERCC3, but not its helicase activity, is required for DNA opening. In transcription, TFIIH has an essential role in transcription initiation . When the pre-initiation complex (PIC) has been established, TFIIH is required for promoter opening and promoter escape . The ATP-dependent helicase activity of XPB/ERCC3 is required for promoter opening and promoter escape. Phosphorylation of the C-terminal tail (CTD) of the largest subunit of RNA polymerase II by the kinase module CAK controls the initiation of transcription. . |
Accessions | A0A2R8YFS3 F2Z2V4 ENST00000426778.5 A0A2R8Y4R8 ENST00000456257.1 P19447 ENST00000646654.1 A0A2R8Y6W8 A0A2R8YES7 A0A2R8Y762 ENST00000445889.5 A0A2R8Y681 ENST00000645504.1 H7C309 ENST00000645233.1 A0A2R8Y5L2 ENST00000645736.1 ENST00000644317.1 ENST00000642308.1 ENST00000647169.1 ENST00000285398.7 A0A2R8Y5H0 ENST00000645467.1 ENST00000647496.1 |